Purpose
To accelerate development of low-cost, liquid RV3-BB rotavirus vaccine at BioFarma for use in Indonesian public markets and Gavi countries through formulation development and bulk process optimization
Grantee
Division
Global Health
Date
JUNE 2016
Region served
GLOBAL
Committed amount
$6,480,214
Grant topic
Enteric and Diarrheal Diseases
Duration (months)
48
Grantee location
Leiden, Zuid-Holland, Netherlands
More about our financials
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.